At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud

For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 4,700 employees in 23 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer and other disease history. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. At Miltenyi Biotec, scientists, engineers, software developers and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians worldwide.

Valneva USA, Inc. Advancing vaccines for better lives.

• Led service delivery team to the successful delivery of hundreds of genomic projects per year • Leveraged project management software to implement a portfolio monitoring system resulting in 20% improvement in bioinformatic reporting turnaround time. • Consulted with sponsors, CROs, and other vendors to create Scopes of Work (SOW) and Data Transfer Agreements (DTA) aligning with study goals and clinical regulations. • Onboarded a ticket-based system to simplify client project communications and improve email response times by 15%. • Collaborated with quality and laboratory teams to align processes with GCP compliance. • Conducted clinical data review, transfer, and reconciliation tasks. • Implemented automated customer satisfaction (CSAT) surveys and monitored responses to identify targets for continual process improvement leading to increased customer success.

Neutron Products, Inc. is a company based out of 22301 Mount Ephraim Road, Dickerson, Maryland, United States.

Over the past 50 years, Chem-Pak has provided customers with specialized custom aerosol and liquid packaging services. In addition, we manufacture a proprietary line of specialty automotive and industrial flaw repair coatings for plastic components. We are proud to offer a turn-key manufacturing solution that has supported the needs and growth of our customers since 1966.

Imagilin® Technology, LLC is a biotechnology company based in Frederick, Maryland, USA. Since 2003, we have been committed to developing innovative technologies and producing nutraceutical products with an emphasis on the company's patented plant-based probiotics to enhance and support human and animal health. We are rapidly expanding throughout the United States and Asian markets with comprehensive involvement in basic research, as well as clinical studies worldwide for all our products. We are dedicated to revolutionizing plant-based products that ensure ethical performance and provide greater value to all of our members and the environment. We collaborate with renowned institutions worldwide to ensure the effectiveness and quality of our products. Imagilin® Technology, LLC is well recognized for its continuous innovation in developing cleaner, healthier supplements that are safe,effective, and held to a higher standard. Currently, our probiotic technology platform and intellectual properties are protected by 8 issued patents and several pending patents in order to support our nutraceutical developments. We market the patented probiotic strain Pediococcus Acidilactici NRRL B-50517 to companies seeking to incorporate this natural ingredient into their dietary supplements and food products. Finished probiotic goods are also readily available to the public as dietary supplements for humans and animals through a channel of retail stores and websites. Find out where you can purchase: https://www.imagilin.com/where-to-buy.

Create your own professional web presence—exactly the way you want. Our powerful technology allows everyone to get online with a personalized, professional web presence. Whether it’s your first time creating or you’re a long time expert, you’ll find the features and solutions you need to build a professional website with total creative freedom. Our global user base, open SDK, and unparalleled design capabilities create a unique ecosystem. Partners, developers, web designers, and other online professionals can effectively market their apps and services to millions through Wix.

AMIVAS is a US, Australian, and European joint venture focused on the development and commercialization of therapeutics for the treatment of life-threatening diseases with offices in the US, Australia and Ireland. AMIVAS manufactures in North America and our partners in Canada, USA and Europe package and supply our product to hospitals and patients in need. AMIVAS’ vision was formed in response to the urgent need for a US and Europe- based firm to assume responsibility for the manufacture and distribution of Artesunate, for the treatment of severe malaria after quinidine gluconate was discontinued in 2019. With the US Food and Drug Administration (FDA) approval of its first commercial product on May 26, 2020, AMIVAS is proud to join the global effort to fight and eradicate malaria.

mdi is a manufacturer of membranes and membrane based products for filtration and separation applications for Biopharmaceutical/Pharmaceutical and Rapid Diagnostics Industries. The company has a history and experience of more than 35 years in membrane production and filtration technology with Sales in more than 50 countries globally. With its state of the art GMP manufacturing facility and extensive product range the company competes with all the major players in the Industry and strives to gain a leadership position on a global scale. mdi production facilities are ISO 9001:2008 certified and some products are ISO 13485 certified for medical use. mdi has a Drug Master File submitted with US FDA. The products meet all stringent demands related to Toxicity, Biosafety, Extractables etc. relevant for the Pharma and Biopharma applications. mdi offers a wide range of high quality, tested and validated products to address all customer needs for Dead-end filtration. Over the years mdi has helped customers to achieve substantial cost savings with its cost effective products and solutions. The ability to deliver customized products and solutions to solve specific problems has always been a differentiator for mdi over competition.

NexImmune is a publicly traded, clinical stage biotechnology company developing unique approaches to T cell immunotherapies based on its propriety Artificial Immune Modulation (AIM™) technology. NexImmune has a differentiated platform and pipeline of product candidates in pre-clinical and phase 1/2 stages with lead programs focused on the treatment of relapsed acute myeloid leukemia (AML) after allogenic stem cell transplantation and multiple myeloma refractory to >3 prior lines of therapy. The AIM technology enables NexImmune to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. By mimicking natural T cell biology, NexImmune’s T cell product candidates are designed to combine the attributes of cellular precision, potency, and persistence with reduced potential for undesired toxicities. For the last decade, the AIM platform has evolved into a stable platform for various therapy targets providing an opportunity to make a massive impact due to its adaptability and flexibility in oncology, autoimmune disorders, infectious disease, and beyond.